"The Foundation for Trustworthy AI: The FAIR Data Playbook for Pharma" details the importance of FAIR data principles (Findable, Accessible, Interoperable, Reusable) for building reliable AI systems in the pharmaceutical sector.

Why It Matters
Forget the shiny AI tools for a moment. If your data isn't FAIR, your AI will be costly, unreliable, and likely non-compliant with the EU AI Act. For a mid-sized European pharma or CRO, this isn't about new tech; it's about getting your house in order. Without FAIR data, you're building on sand.
What To Do About It
I can conduct a rapid data readiness assessment for your existing data infrastructure and outline a practical FAIR data strategy, fully compliant with GDPR and the EU AI Act, in 2-3 weeks.
Sources
Related Signals

Flagright, a new AI operating system for compliance, just secured $12.5M in funding.
17 Jun 2026
Pharma compliance is actively adapting to new AI tools and emerging regulation.
6 Jun 2026
Weverse Brain was selected for South Korea's Ministry of Science and ICT's "Advanced GPU Utilization Support Project".
2 Jun 2026